The medical management of obesity has taken precedence as a mode for weight management with the advent of glucagon-like peptide-1 (GLP-1) receptor agonists, which have proven to be effective in inducing weight loss and maintaining it. This evidence concerns the gene GCG and obesity due to melanocortin 4 receptor deficiency.